Gas and Gas Pains

Clinically reviewed Aug 29, 2026 Updated Aug 30, 2026

Clinical Snapshot

Gas and gas pains — the constellation of flatulence, belching, and bloating — is one of the most common presentations a community pharmacist manages as self-care. The average person passes gas 13-21 times a day and produces roughly 2 litres of intestinal gas over that same day as a normal part of digestion.[1] Intestinal gas comes from two distinct sources: swallowed air (aerophagia) — from eating or talking quickly, chewing gum, drinking through a straw, carbonated beverages, or smoking — and colonic bacterial fermentation of undigested carbohydrates, which is the dominant contributor to the bloating and flatulence that actually bring patients to the pharmacy counter.[2] Bloating (the subjective feeling of fullness) and distension (a visible, measurable increase in abdominal girth) are related but distinct, and most bloating occurs without measurable distension.[1]

The pharmacist's role here is genuinely two-part: a brief structured assessment to screen out the uncommon but important cases where gas and bloating are a symptom of something else — irritable bowel syndrome (IBS), lactose intolerance, celiac disease, or small intestinal bacterial overgrowth (SIBO) — and, for the large majority of patients with simple functional gas, practical, honest guidance on dietary triggers plus a modest, well-matched role for OTC products rather than reflexively recommending a single "gas drop" as a cure-all.

Recognize the Condition

Mechanism

Swallowed air is mostly nitrogen and oxygen and is largely relieved by belching before it ever reaches the colon.[2] The gas responsible for most flatulence and bloating complaints instead originates in the colon: fermentable carbohydrates that escape digestion and absorption in the small intestine — FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) — pass into the colon, where resident bacteria ferment them, producing hydrogen, carbon dioxide, and, in a subset of people, methane, along with short-chain fatty acids.[2][3] The amount of gas produced from an identical meal varies enormously between individuals, reflecting real differences in gut microbial composition, fermentation efficiency, and how efficiently gas is reabsorbed across the colonic wall — a genuinely useful point for normalizing one patient's experience relative to another's.[3]

Presentation

Patients typically describe some combination of audible or palpable bowel sounds, a subjective feeling of fullness or pressure, visible abdominal distension, excessive belching, or excessive flatulence, often clustering after specific meals or later in the day. Symptoms are frequently intermittent and food-linked rather than constant or progressive.

How common is this

Gas and bloating are near-universal complaints — passing gas 13-21 times a day and producing about 2 litres of gas daily is itself the normal range, not a sign of excess.[1] A genuinely overlapping and more specific condition, irritable bowel syndrome, is common in its own right, affecting roughly 10% of the general population globally and an estimated 12% of the North American population, with bloating as one of its core associated symptoms.[4]

Risk Factors

Dietary triggers — FODMAPs

The foods most consistently linked to gas and bloating are fermentable, poorly absorbed carbohydrates, commonly grouped under the FODMAP acronym:[2]

  • Oligosaccharides (fructans and galacto-oligosaccharides) — wheat, rye, onions, garlic, legumes, and lentils.
  • Disaccharides — lactose — dairy products, in anyone with reduced lactase activity (see Assessment & Diagnosis).
  • Monosaccharides — excess fructose — apples, pears, stone fruits, and high-fructose corn syrup.
  • Polyols — sorbitol, mannitol, xylitol, and erythritol, common in sugar-free gum, candy, and "diet" products.
  • Cruciferous vegetables (broccoli, cabbage, Brussels sprouts, cauliflower) and mushrooms, through a mix of oligosaccharide and fibre content.

Behavioural and eating-habit triggers (aerophagia)

  • Eating or drinking quickly, and talking while eating.
  • Chewing gum and sucking on hard candy.
  • Drinking through a straw, and carbonated beverages.
  • Smoking.
  • A poorly fitting denture and chronic post-nasal drip, both of which increase unconscious air swallowing.[5]

Other contributing factors

  • A rapid increase in dietary fibre without a gradual ramp-up — the general target is 25-38 g of fibre daily, but getting there too quickly is a common, avoidable cause of a new-onset gas complaint.[1]
  • Constipation, which allows more time for colonic fermentation before gas is passed.[2]
  • An underlying condition — IBS, lactose intolerance, celiac disease, or SIBO — in patients whose symptoms are more persistent, severe, or out of proportion to diet (see Assessment & Diagnosis).

Red Flags & Refer

Gas and bloating are usually benign and self-limited, but any of the following means self-care is not appropriate and the patient needs medical referral instead:

  • Unintentional weight loss.
  • Blood in the stool or other gastrointestinal bleeding.
  • Severe abdominal pain, or pain that is progressively worsening rather than the typical crampy, intermittent discomfort of simple gas.
  • Fever.
  • Symptoms significantly interfering with daily function — work, sleep, or usual activities.
  • New onset in a patient 50 years of age or older without prior evaluation — current Canadian guidance specifically recommends colonoscopy for new-onset bowel symptoms at or after age 50, independent of how classic the symptoms otherwise look for a benign cause.[4]
  • Other alarm features that warrant the same threshold: vomiting, difficulty swallowing, an abdominal mass, or anemia.[4]

Any of these findings should prompt consideration of inflammatory bowel disease, malignancy, or another organic cause rather than continued self-care — refer rather than trialing another OTC product first.[4]

Assessment & Diagnosis

The pharmacist's assessment

A brief, structured history is usually enough to separate simple functional gas from a condition that needs further workup: onset and duration, timing relative to meals, specific foods or drinks that seem to trigger symptoms, associated bowel habit (constipation, diarrhea, or a mix), and — first and always — a screen for the red flags above.

Differentiating simple functional gas from conditions that need further workup

ConditionDistinguishing cluesPractical point
Simple functional gas/bloatingSymptoms clearly linked to specific foods or eating habits; mild-to-moderate severity; no red flags; otherwise wellThe large majority of patients presenting at the pharmacy counter — appropriate for self-care and dietary-trigger counselling.
Irritable bowel syndrome (IBS)Recurrent abdominal pain at least 1 day per week for the last 3 months, associated with defecation or a change in bowel habit (the Rome IV criteria), with bloating a very common associated symptomA common and genuinely overlapping diagnosis, affecting roughly 10-12% of the population — consider it when gas/bloating comes with a consistent pain-and-bowel-habit pattern rather than existing in isolation.[4]
Lactose intoleranceSymptoms specifically and consistently linked to dairy intake; up to about 70% of adults worldwide lose sufficient lactase activity by adulthood, with higher rates in people of non-European descentA dietary trial of lactose restriction, or a lactase supplement trial, is a reasonable first step; hydrogen breath testing is available if the diagnosis remains unclear.[3]
Celiac diseaseBloating alongside chronic diarrhea, unintentional weight loss, iron-deficiency anemia, or a family history of celiac diseaseThese additional features should prompt referral for serologic testing rather than assuming a dietary FODMAP or lactose trigger.
Small intestinal bacterial overgrowth (SIBO)Persistent or severe bloating and flatulence, sometimes with diarrhea or features of malabsorption, not responding to a reasonable dietary and OTC self-care trialA less common but important differential specifically for the patient whose symptoms are persistent, severe, or fail an adequate self-care trial; diagnosis is typically by breath testing and is not a pharmacy-based assessment.[6]

Investigations

No testing is needed for simple, food-linked functional gas and bloating without red flags. When the history instead fits IBS, lactose intolerance, celiac disease, or SIBO, direct the patient toward the appropriate next step — a primary care visit for celiac serology or breath testing, or a continued, self-directed dietary trial with reassessment — rather than attempting to order or improvise testing from the pharmacy.

Treatment Targets

  • Relieve troublesome symptoms — a reasonable, achievable goal, not the elimination of all intestinal gas, which is a normal physiological process.
  • Identify and reduce genuinely modifiable dietary and behavioural triggers through a systematic trial rather than broad, unguided food restriction.
  • Select an OTC product rationally, matched to the likely mechanism, with honest expectations about the generally modest evidence behind each option.
  • Recognize when self-care is not appropriate — screen for red flags at the outset and again if a self-care trial fails — and refer promptly rather than cycling through further products.

Choose Initial Treatment

Direct treatment rule

Every patient

1st line, every patient screen for red flags first (see Red Flags & Refer); if none are present, start with dietary and behavioural trigger reduction (see Non-Pharmacologic Treatment) before reaching for a product — most functional gas responds at least partially to identifying and moderating specific triggers.[7]

Choosing an OTC product, matched to the likely cause

Consider — generalized bloating/trapped-gas discomfort a trial of simethicone; it is extremely well tolerated and a reasonable first OTC option, but set expectations honestly — evidence for symptom benefit is modest, and it works by helping swallowed or trapped gas bubbles coalesce for easier passage rather than by reducing how much gas the colon actually produces.[8]

Consider — gas specifically after legumes or cruciferous vegetables alpha-galactosidase (Beano-type products), taken with the first bite of the trigger food; trial evidence specifically supports a reduction in flatulence episodes after a meal containing these foods.[9]

Consider — symptoms specifically linked to dairy a lactase enzyme supplement taken with dairy intake, alongside (or instead of) a dietary lactose-reduction trial — see Assessment & Diagnosis.[3]

Use activated charcoal only selectively, if at all evidence for benefit is conflicting — an early trial suggested a reduction in flatus frequency, but a later double-blind trial found no clear advantage over placebo — and it meaningfully reduces the absorption of many co-administered oral medications, which is the bigger practical concern for most patients who ask about it.[10][11][12]

Consider — an adjunct, particularly with an IBS-like pattern a probiotic trial of at least 2-4 weeks; evidence is real but strain-specific and still emerging — present this as a reasonable option to try, not an established, guaranteed remedy.[13][4]

Non-Pharmacologic Treatment

Dietary modification

A systematic trial elimination of the most likely trigger foods — legumes, cruciferous vegetables, dairy (if lactose intolerance is suspected), high-fructose fruits, and polyol-containing sugar-free products — for a defined period, followed by a deliberate one-at-a-time reintroduction, is more useful and more sustainable than broad, unguided long-term restriction; the goal is to identify the patient's own specific triggers, not to permanently avoid every FODMAP-containing food.[2] If fibre intake is being increased, do it gradually toward the general target of 25-38 g daily rather than all at once.[1]

Eating habits and behaviour

  • Eat and drink slowly, and avoid talking while eating — both reduce swallowed air.
  • Limit carbonated beverages, chewing gum, and drinking through a straw.
  • Eat smaller, more frequent meals rather than large ones.
  • Address a poor denture fit or chronic post-nasal drip if either is contributing to air swallowing.[5]

Physical activity

Regular physical activity, including simply walking, supports normal gut motility and can help move trapped gas along; gentle movement (walking or yoga) is a reasonable, low-risk recommendation for an acute episode of trapped-gas discomfort.[7]

Complementary options with modest evidence

Peppermint (including enteric-coated peppermint products) and ginger are commonly recommended by dietitians for bloating and are reasonable to mention as low-risk adjuncts, though the evidence specifically for gas and flatulence is less robust than for other functional GI symptoms.[7]

Patient education

Reassure patients that passing gas 13-21 times a day and producing roughly 2 litres of gas daily is itself the normal range — the goal of treatment is comfort and symptom control, not eliminating gas entirely.[1] Explain the difference between bloating (a feeling) and distension (a visible change) so patients have accurate language for what they are experiencing, and set honest expectations for any OTC product recommended — most have modest, not dramatic, evidence behind them, and identifying and moderating personal dietary triggers is usually the more powerful intervention.[1]

Pharmacologic Treatment Options

Drug / interventionRoleDose / useImportant adverse effectsTeaching points
Simethicone
Consider
First-line OTC option for generalized bloating or trapped-gas discomfort80-125 mg PO after meals and at bedtime, as needed (per product labelling)None significant; not systemically absorbedAnti-foaming agent — coalesces gas bubbles for easier passage; does not reduce how much gas is produced. Evidence for benefit is genuinely modest — set expectations honestly rather than presenting it as a guaranteed fix.
Alpha-galactosidase (Beano-type products)
Consider
Gas specifically anticipated from legumes or cruciferous vegetablesPer product labelling (tablets or drops) with the first bite of the trigger foodNone significantTrial evidence supports reduced flatulence specifically after these foods; not a general-purpose remedy for gas from other causes.
Lactase enzyme supplements
Consider
Gas/bloating specifically linked to dairy intake in a patient with suspected lactose intolerancePer product labelling (tablets, caplets, or drops added to milk) with the first bite or sip of dairyNone significantOnly helps when lactose intolerance is the actual driver — confirm a dairy-linked pattern before recommending, and consider a trial lactose elimination in parallel.
Activated charcoal
Use selectively
Not a preferred first choice; evidence for benefit is conflictingPer product labelling; no well-established optimal dose for this indicationBlack stools, GI upsetReduces the absorption and effectiveness of many co-administered oral medications through nonselective adsorption — counsel patients on other regular medications to separate dosing by several hours, or choose a different option first.
Probiotics (strain-specific)
Consider
Adjunct for bloating/flatulence, particularly with an IBS-like patternProduct- and strain-specific; trial for at least 2-4 weeks before assessing benefitGenerally well tolerated; mild transient bloating possible when startingEvidence is real but strain-specific and still emerging — do not present 'probiotics' generically as a proven fix; benefit shown for specific strains in specific trials only.

Special Populations

Pregnancy

Gas and bloating are common in pregnancy, driven by progesterone-related slowing of GI motility plus mechanical compression from the growing uterus in later trimesters. Dietary and behavioural modification remain first-line. Simethicone is not systemically absorbed and is generally considered a reasonable option in pregnancy; confirm any product recommendation beyond simethicone against current pregnancy-safety information and the patient's own prenatal care team.

Breastfeeding

Simethicone's lack of systemic absorption also makes it a reasonable option while breastfeeding. Note that this chapter addresses gas and bloating in the breastfeeding parent themselves — a crying, gassy infant is a distinct presentation, covered in the separate Infantile Colic chapter, where the evidence and management (including the lack of benefit for infant simethicone) does not carry over to an adult's own symptoms.

Older adults

Keep a lower threshold for red-flag concern — current Canadian guidance specifically recommends colonoscopy for new-onset bowel symptoms at or after age 50, so a first presentation of gas/bloating in this group should not be assumed benign without confirming there is no red flag or need for referral.[4] Also consider whether a medication the patient already takes is contributing to increased gas as a side effect before reflexively adding another product.

Patients taking other oral medications

If activated charcoal is used, counsel explicitly on separating its dosing by several hours from all other oral medications — it reduces the absorption of a wide range of co-administered drugs (including propranolol, rifampin, and phenobarbital, among others) through the same nonselective adsorption that makes it useful in overdose management.[12] This interaction risk, more than any efficacy concern, is the main reason to reach for a different OTC option first in a patient on regular medications.

Renal and hepatic impairment

Simethicone, alpha-galactosidase, lactase, and activated charcoal are not systemically absorbed, so no dose adjustment is needed for renal or hepatic impairment; select a probiotic product on its own merits, since there is no specific renal/hepatic dosing consideration for these either.

Monitoring & Follow-Up

Set a specific point to reassess — about 1-2 weeks after starting a dietary-trigger trial or an OTC product — rather than leaving follow-up open-ended.

  • Confirm the trial was actually completed as discussed (the specific trigger food avoided, or the product taken correctly and consistently) before concluding it "didn't work."
  • Track a realistic outcome: reduced frequency/severity of bothersome symptoms, not the complete disappearance of all gas, which is not a realistic or necessary goal.[1]
  • If a dietary elimination trial helped, guide a deliberate, one-at-a-time reintroduction to confirm which specific food (or foods) was actually responsible, rather than leaving the patient on an unnecessarily restrictive diet indefinitely.
  • Re-screen for any new red flag at follow-up, since a self-care trial that is not working is itself a reason to reassess the working diagnosis, not just to try a different product.

Treatment Failure / Next Step

  1. Confirm the trial was adequate first — the right product, taken correctly, for a reasonable duration (at least 1-2 weeks; probiotics may need 2-4 weeks) — before concluding it has failed.
  2. If a specific dietary trigger trial did not help, reconsider whether the trigger identified was actually the right one, or whether a broader pattern (consistent with IBS, lactose intolerance, celiac disease, or SIBO) fits better — see Assessment & Diagnosis.
  3. If symptoms persist despite an adequate trial of dietary modification and a reasonably matched OTC product, refer for medical assessment rather than moving on to a further unproven product.
  4. If a red flag emerges at any point — during the initial assessment or after an apparent self-care failure — refer promptly regardless of how the self-care trial was otherwise going.
  5. If symptoms are clearly and consistently tied to dairy despite a lactase trial, or to legumes/cruciferous vegetables despite an alpha-galactosidase trial, reconsider the diagnosis rather than simply escalating the dose or switching brands.

Common Errors to Avoid

  • Reflexively recommending simethicone (or any single product) without a brief dietary-trigger history — the history itself is often more useful than any product.
  • Presenting simethicone, alpha-galactosidase, or probiotics as guaranteed fixes rather than honestly modest, selectively useful options — this is a well-established pattern of overselling OTC "gas relief" products that pharmacists are well positioned to correct.[8]
  • Recommending activated charcoal without asking about other current medications, given its nonselective adsorption of many co-administered oral drugs.[12]
  • Recommending broad, long-term FODMAP or dairy restriction without a plan for systematic reintroduction — this risks unnecessary dietary restriction and nutritional gaps for a benign, generally food-trigger-specific complaint.
  • Treating "just gas" as inherently benign without a red-flag screen, particularly in a patient 50 years of age or older with new-onset symptoms.[4]
  • Missing an underlying diagnosis (IBS, lactose intolerance, celiac disease, or SIBO) in a patient whose symptoms are persistent, severe, or clearly not responding to a reasonable self-care trial, rather than simply trying another OTC product.
  • Failing to reassure patients that a genuinely normal amount of gas (13-21 episodes and about 2 litres a day) is itself not a problem — this alone resolves a meaningful share of pharmacy consultations.[1]

Clinical Decision Algorithm

Algorithm A — Initial assessment
Patient presents with gas, bloating, or flatulence
Brief history: onset/duration, timing relative to meals, specific food/drink triggers, bowel habit pattern, and a red-flag screen[4]
A red flag is present (unintentional weight loss, blood in stool, severe or worsening pain, fever, symptoms significantly limiting daily function, or new onset at age 50 or older without prior evaluation)
Refer for medical assessment — do not continue self-care[4]
No red flag; symptoms are food-linked and consistent with normal gas production
Reassure that passing gas 13-21 times a day and about 2 L a day is itself normal; proceed to Algorithm B[1]
Algorithm B — Trigger identification and self-care
No red flags — proceed with self-care
Take a brief dietary-trigger history: legumes/cruciferous vegetables, dairy, high-fructose fruit, carbonated beverages, artificial sweeteners, gum, and eating pace[2]
Pattern points to legumes or cruciferous vegetables
Dietary moderation of the trigger food, plus a trial of alpha-galactosidase taken with the first bite[9]
Pattern points specifically to dairy
Trial lactose reduction, plus a lactase supplement taken with dairy intake[3]
No single trigger identified; generalized bloating/trapped-gas discomfort
General dietary and behavioural modification (eat slowly, reduce carbonated drinks/gum/straws, regular physical activity), plus consider a simethicone trial[7][8]
Improves within about 1-2 weeks
Continue the identified trigger-avoidance strategy and, if a dietary trial helped, reintroduce foods one at a time to confirm the specific trigger
No improvement, or a new red flag emerges
Reassess for an underlying cause — IBS, lactose intolerance, celiac disease, or SIBO — and refer rather than trying another product[6]

Drug Tables

How to use this table: none of the agents below have a standalone Pharmasist Drug Database monograph, so names are shown as plain text. Doses reflect typical adult self-care labelling — confirm against the specific product's own label, since OTC gas-relief formulations vary by strength and combination product.

OTC options with modest but genuine supporting evidence

Reasonable first-line self-care options with a favourable safety profile; set expectations honestly about the size of the expected benefit.

Drug/interventionDosageAdverse effectsDrug interactionsComments
Simethicone
Adults: 80-125 mg PO after meals and at bedtime, as needed (per product labelling; typical maximum around 500 mg/day)
None significant; not systemically absorbedNone significantAnti-foaming agent — coalesces gas bubbles for easier passage; does not reduce the amount of gas produced. Evidence for symptom benefit is genuinely modest, based on older placebo-controlled trial data, not a guaranteed fix.

Trigger-specific enzyme options

Match the product to a specific suspected trigger rather than using either as a general-purpose remedy.

Drug/interventionDosageAdverse effectsDrug interactionsComments
Alpha-galactosidase (Beano-type products)
Adults: Per product labelling (tablets or drops) taken with the first bite of the trigger food
None significantNone significantReduces flatulence specifically tied to legume and cruciferous-vegetable oligosaccharides in trial evidence; not shown to help gas from other causes.
Lactase enzyme supplements
Adults: Per product labelling (tablets, caplets, or drops added to milk) taken with the first bite/sip of dairy
None significantNone significantHelps only when lactose intolerance is the actual driver of symptoms — confirm a dairy-linked pattern, or consider a trial lactose elimination, before recommending.

Options with weaker or mixed evidence

Included because patients frequently ask about these — not because either is a preferred first choice.

Drug/interventionDosageAdverse effectsDrug interactionsComments
Activated charcoal
Adults: Per product labelling; no well-established optimal dose for this indication
Black stools, GI upsetReduces the absorption and effectiveness of many concurrently administered oral medications (e.g., propranolol, rifampin, phenobarbital, hormonal contraceptives) through nonselective adsorption — separate dosing by several hours from all other oral drugsEvidence for benefit in intestinal gas is conflicting: an early trial suggested a reduction in flatus frequency after a gas-producing meal, while a later double-blind trial found no clear advantage over placebo.
Probiotics (strain-specific, e.g., Bacillus coagulans)
Adults: Per product labelling; typically continued for a minimum 2-4 week trial
Generally well tolerated; mild transient bloating possible when startingNone significantEvidence is real but strain-specific and still emerging — benefit shown for bloating/flatulence scores with specific strains in specific trials, not established as a general class effect; allow at least 2-4 weeks before assessing benefit.

References

  1. Top Tips for Digestive Troubles — Canadian Digestive Health Foundation. CDHF patient resource, updated November 16, 2022
  2. IBS Bloating & Gas Explained — Canadian Digestive Health Foundation (Roocroft J, RD). CDHF patient resource, updated March 30, 2026
  3. What is Lactose Intolerance? Symptoms and Treatment — Canadian Digestive Health Foundation. CDHF patient resource, updated December 1, 2022
  4. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS) — Journal of the Canadian Association of Gastroenterology (Moayyedi P, Andrews CN, MacQueen G, et al.). J Can Assoc Gastroenterol 2019;2(1):6-29
  5. Gas — American Gastroenterological Association, GI Patient Center. AGA GI Patient Center patient resource
  6. Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management — Gastroenterology (Bushyhead D, Quigley EMM). Gastroenterology 2022;163(3):593-607
  7. Dietitian-Approved Strategies to Help Reduce Bloating — Canadian Digestive Health Foundation (Health Stand Nutrition Dietitian Team). CDHF patient resource, updated July 27, 2026
  8. Simethicone — StatPearls, StatPearls Publishing (Ingold CJ, Akhondi H). StatPearls [Internet], updated 2023-07-03
  9. Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance — The Journal of Family Practice (Ganiats TG, Norcross WA, Halverson AL, Burford PA, Palinkas LA). J Fam Pract 1994;39(5):441-445
  10. Effects of orally administered activated charcoal on intestinal gas — American Journal of Gastroenterology (Hall RG 3rd, Thompson H, Strother A). Am J Gastroenterol 1981;75(3):192-196
  11. Activated charcoal, simethicone, and intestinal gas: a double-blind study — Annals of Internal Medicine (Jain NK, Patel VP, Pitchumoni CS). Ann Intern Med 1986;105(1):61-62
  12. Activated Charcoal — StatPearls, StatPearls Publishing (Taylor A, Galuska MA, Patel P). StatPearls [Internet], updated 2026-04-18
  13. The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study — Medicine (Majeed M, Nagabhushanam K, Paulose S, Arumugam S, Mundkur L). Medicine (Baltimore) 2023;102(9):e33109

Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.